drugset / Trial / NCT07360275
A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to explore the safety and efficacy of VCT220 for the treatment of hypertension in participants with obesity or overweight.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2026-10-20
- Completion
- 2026-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VCT220 | Small molecule | 80 mg | Oral |
| Subject | VCT220 | Small molecule | 160 mg | Oral |